Crescita Therapeutics Stock Forward View - Daily Balance Of Power
| CTX Stock | CAD 0.49 0.01 2.08% |
Crescita Stock outlook is based on your current time horizon. Although Crescita Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Crescita Therapeutics' systematic risk associated with finding meaningful patterns of Crescita Therapeutics fundamentals over time.
As of today the relative strength index (rsi) of Crescita Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 0.287 | Quarterly Revenue Growth 0.501 |
Using Crescita Therapeutics hype-based prediction, you can estimate the value of Crescita Therapeutics from the perspective of Crescita Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Crescita Therapeutics after-hype prediction price | CAD 0.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Crescita |
Crescita Therapeutics Additional Predictive Modules
Most predictive techniques to examine Crescita price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Crescita using various technical indicators. When you analyze Crescita charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (1.00) | 9.2 T |
| Check Crescita Therapeutics Volatility | Backtest Crescita Therapeutics | Information Ratio |
Crescita Therapeutics Trading Date Momentum
| On February 11 2026 Crescita Therapeutics was traded for 0.49 at the closing time. The maximum traded price for the trading interval was 0.49 and the lowest daily price was 0.49 . The daily volume was recorded at 750. The volume of trading on 11th of February 2026 did not affect price variability. The overall trading delta to the closing price today is 0.00% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Crescita Therapeutics to competition |
Other Forecasting Options for Crescita Therapeutics
For every potential investor in Crescita, whether a beginner or expert, Crescita Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Crescita Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Crescita. Basic forecasting techniques help filter out the noise by identifying Crescita Therapeutics' price trends.Crescita Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Crescita Therapeutics stock to make a market-neutral strategy. Peer analysis of Crescita Therapeutics could also be used in its relative valuation, which is a method of valuing Crescita Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Crescita Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Crescita Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Crescita Therapeutics shares will generate the highest return on investment. By undertsting and applying Crescita Therapeutics stock market strength indicators, traders can identify Crescita Therapeutics entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.49 | |||
| Day Typical Price | 0.49 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
Crescita Therapeutics Risk Indicators
The analysis of Crescita Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Crescita Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting crescita stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.67 | |||
| Semi Deviation | 2.43 | |||
| Standard Deviation | 2.67 | |||
| Variance | 7.12 | |||
| Downside Variance | 24.37 | |||
| Semi Variance | 5.89 | |||
| Expected Short fall | (2.82) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Crescita Therapeutics
The number of cover stories for Crescita Therapeutics depends on current market conditions and Crescita Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Crescita Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Crescita Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Crescita Therapeutics Short Properties
Crescita Therapeutics' future price predictability will typically decrease when Crescita Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Crescita Therapeutics often depends not only on the future outlook of the potential Crescita Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Crescita Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.3 M | |
| Cash And Short Term Investments | 9.3 M |
Other Information on Investing in Crescita Stock
Crescita Therapeutics financial ratios help investors to determine whether Crescita Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.